Core 2: Bioinformatics/Biostatistics/Genomics
- Institution
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA
- Principal investigator
- Pablo Tamayo
- Funding
- $1.3M
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
CORE 2 PROJECT SUMMARY Key to this proposal is the inclusion of Core 2, which encompasses unified support for Bioinformatics, Biostatistics, Genomics, Transcriptomics, and Computational Biology and the development of an integrated analytical platform that will consolidate all the computational methods and tools developed or adapted to accomplish each of the projects’ research agendas. Core 2 will provide support for both exploratory and hypothesis-free analyses as well as for hypothesis-driven targeted identification of the molecules and pathways identified in the research programs of each of the three projects. For example, a detailed analysis of the sequencing data generated by the projects will reveal the changes in the somatic mutations, driver mutations, clonal evolution, and mutational signatures due to hypernutrition and metabolic stress. This core will also maintain a database linking all the biospecimens, organoids, PDOXs, and the associated data from all projects and cores. As the different projects generate data, this core will integrate the data with analysis modalities to identify, e.g., novel pathways and cross-talk between NRF2, ATF6, SAB, and other identified biomarkers.
LOADING MOONBASE SCORE
Questions for SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Sanford Burnham Prebys Medical Discovery InstituteNot yet scored
Identification of microproteins associated with hematopoiesis and related diseases
Aniruddha J. Deshpande · $293K · 2025–2027
- NIH · Sanford Burnham Prebys Medical Discovery InstituteNot yet scored
PIKfyve regulates pH homeostasis and tumor growth in pancreatic cancer
Shea Grenier Davis · $41K · 2025–2028
- NIH · Sanford Burnham Prebys Medical Discovery InstituteNot yet scored
Immune Checkpoint Blockade Targeting the Novel PSGL-1/VISTA Axis for Pancreatic Cancer
Linda Mac Pherson Bradley · $268K · 2025–2027